Home
|
Inbox
|
Search
|
View Abstract
First Identification of Krüppel-Like Factor 2 Mutation in Heritable Pulmonary Arterial Hypertension
Description
.abstract img { width:300px !important; height:auto; display:block; text-align:center; margin-top:10px } .abstract { overflow-x:scroll } .abstract table { width:100%; display:block; border:hidden; border-collapse: collapse; margin-top:10px } .abstract td, th { border-top: 1px solid #ddd; padding: 4px 8px; } .abstract tbody tr:nth-child(even) td { background-color: #efefef; } .abstract a { overflow-wrap: break-word; word-wrap: break-word; }
A4631 - First Identification of Krüppel-Like Factor 2 Mutation in Heritable Pulmonary Arterial Hypertension
Author Block: C. Eichstaedt1, J. Song1, R. Rodríguez Viales2, Z. Pan1, N. Benjamin1, C. Fischer3, M. Hoeper4, S. Ulrich5, K. Hinderhofer3, E. Gruenig1; 1Center for pulmonary hypertension, Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany, 2European Molecular Biology Lab, Heidelberg, Germany, 3Institute for Human Genetics, Heidelberg University, Heidelberg, Germany, 4Hannover Medical School, Hannover, Germany, 5University Hospital Zurich, Zurich, Switzerland.
Rationale: Heritable pulmonary arterial hypertension (HPAH) is an autosomal dominantly inherited disease caused by mutations in the bone morphogenic protein receptor 2 gene and/or genes of its signalling pathway in about 85% of patients. Our main objective was to identify the genetic cause of the disease in this family using an NGS based PAH-specific gene panel including all so far known PAH and further candidate genes.
Methods: We clinically and genetically analysed a HPAH family without mutations in previously described PAH genes. Clinical assessment included electrocardiogram, lung function, blood gas analysis, chest X-ray, laboratory testing, echocardiography and right heart catheterisation in case of suspected disease. Genetic diagnostics were performed using a PAH-specific gene panel including all known 12 PAH genes and 20 further candidate genes by next-generation-sequencing.
Results: HPAH was invasively confirmed in two sisters and their father who died aged 32 years. No signs of HPAH were detected in five first degree family members. Both sisters were lung transplanted and remained stable during a follow-up of >20 years. We detected a novel missense mutation in the Krüppel-like factor 2 (KLF2) likely leading to a disruption of gene function. The same KLF2 mutation has been described as a recurrent somatic mutation in B-cell lymphoma. Neither the healthy family members carried the mutation nor >120,000 controls.
Conclusion: These findings point to KLF2 as a new PAH gene. Further studies are needed to assess frequency and implication of KLF2 mutations in PAH patients.
Author Block: C. Eichstaedt1, J. Song1, R. Rodríguez Viales2, Z. Pan1, N. Benjamin1, C. Fischer3, M. Hoeper4, S. Ulrich5, K. Hinderhofer3, E. Gruenig1; 1Center for pulmonary hypertension, Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany, 2European Molecular Biology Lab, Heidelberg, Germany, 3Institute for Human Genetics, Heidelberg University, Heidelberg, Germany, 4Hannover Medical School, Hannover, Germany, 5University Hospital Zurich, Zurich, Switzerland.
Rationale: Heritable pulmonary arterial hypertension (HPAH) is an autosomal dominantly inherited disease caused by mutations in the bone morphogenic protein receptor 2 gene and/or genes of its signalling pathway in about 85% of patients. Our main objective was to identify the genetic cause of the disease in this family using an NGS based PAH-specific gene panel including all so far known PAH and further candidate genes.
Methods: We clinically and genetically analysed a HPAH family without mutations in previously described PAH genes. Clinical assessment included electrocardiogram, lung function, blood gas analysis, chest X-ray, laboratory testing, echocardiography and right heart catheterisation in case of suspected disease. Genetic diagnostics were performed using a PAH-specific gene panel including all known 12 PAH genes and 20 further candidate genes by next-generation-sequencing.
Results: HPAH was invasively confirmed in two sisters and their father who died aged 32 years. No signs of HPAH were detected in five first degree family members. Both sisters were lung transplanted and remained stable during a follow-up of >20 years. We detected a novel missense mutation in the Krüppel-like factor 2 (KLF2) likely leading to a disruption of gene function. The same KLF2 mutation has been described as a recurrent somatic mutation in B-cell lymphoma. Neither the healthy family members carried the mutation nor >120,000 controls.
Conclusion: These findings point to KLF2 as a new PAH gene. Further studies are needed to assess frequency and implication of KLF2 mutations in PAH patients.
|
Home
|
Inbox
|
Search
|